Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

A new study examines how cost, side effects and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

Discover how modern diabetes medications offer cardiovascular benefits, transforming diabetes care and improving outcomes worldwide.

A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

This led them to the conclusion that antibiotics, antivirals and anti-inflammatory drugs were all associated with reduced ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

New research found that over half of people with type 2 diabetes in the Americas may be deficient in essential nutrients, ...

Figuring out how your genes and environment increase your likelihood of developing asthma, heart disease, cancer, dementia ...